JM Financial has reiterated its ‘Buy’ rating on Nykaa, raising the target price to Rs 250, reflecting a 15% upside from the previous day’s Rs 217 closing price. The upgrade is driven by Nykaa’s strong FY24 performance and strategic market positioning.
Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%
Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its target